These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 12400891

  • 1. Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing care population.
    Hirji Z, O'Grady S, Bonham J, Mak M, Takata-Shewchuk J, Hawkins K, Gardam M, Law L, Mazzulli T, Conly J.
    Infect Control Hosp Epidemiol; 2002 Oct; 23(10):604-8. PubMed ID: 12400891
    [Abstract] [Full Text] [Related]

  • 2. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home.
    Lee C, Loeb M, Phillips A, Nesbitt J, Smith K, Fearon M, McArthur MA, Mazzulli T, Li Y, McGeer A.
    Infect Control Hosp Epidemiol; 2000 Nov; 21(11):700-4. PubMed ID: 11089653
    [Abstract] [Full Text] [Related]

  • 3. Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.
    Hirji Z, O'Grady S, Bonham J, Mak M, Takata-Shewchuk J, Hawkins K, Gardam M, Law L, Mazzulli T, Conly J.
    Can Commun Dis Rep; 2001 Feb 01; 27(3):21-4. PubMed ID: 11227819
    [No Abstract] [Full Text] [Related]

  • 4. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.
    Hedrick JA, Barzilai A, Behre U, Henderson FW, Hammond J, Reilly L, Keene O.
    Pediatr Infect Dis J; 2000 May 01; 19(5):410-7. PubMed ID: 10819336
    [Abstract] [Full Text] [Related]

  • 5. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population.
    Gravenstein S, Drinka P, Osterweil D, Schilling M, Krause P, Elliott M, Shult P, Ambrozaitis A, Kandel R, Binder E, Hammond J, McElhaney J, Flack N, Daly J, Keene O.
    J Am Med Dir Assoc; 2005 May 01; 6(6):359-66. PubMed ID: 16286056
    [Abstract] [Full Text] [Related]

  • 6. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
    Monto AS, Pichichero ME, Blanckenberg SJ, Ruuskanen O, Cooper C, Fleming DM, Kerr C.
    J Infect Dis; 2002 Dec 01; 186(11):1582-8. PubMed ID: 12447733
    [Abstract] [Full Text] [Related]

  • 7. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, Sharp SJ, Ossi MJ, Zanamivir Family Study Group.
    N Engl J Med; 2000 Nov 02; 343(18):1282-9. PubMed ID: 11058672
    [Abstract] [Full Text] [Related]

  • 8. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
    Lancet; 1998 Dec 12; 352(9144):1877-81. PubMed ID: 9863784
    [Abstract] [Full Text] [Related]

  • 9. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, Webster A.
    J Infect; 2000 Jan 12; 40(1):42-8. PubMed ID: 10762110
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G, Gillissen A.
    Med Microbiol Immunol; 2002 Dec 12; 191(3-4):169-73. PubMed ID: 12458354
    [Abstract] [Full Text] [Related]

  • 11. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population.
    Ambrozaitis A, Gravenstein S, van Essen GA, Rubinstein E, Balciuniene L, Stikleryte A, Crawford C, Elliott M, Shult P.
    J Am Med Dir Assoc; 2005 Dec 12; 6(6):367-74. PubMed ID: 16286057
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K.
    N Engl J Med; 1997 Sep 25; 337(13):874-80. PubMed ID: 9302301
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS, Fleming DM, Henry D, de Groot R, Makela M, Klein T, Elliott M, Keene ON, Man CY.
    J Infect Dis; 1999 Aug 25; 180(2):254-61. PubMed ID: 10395837
    [Abstract] [Full Text] [Related]

  • 14. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb 25; 15(81):21-30. PubMed ID: 16548114
    [Abstract] [Full Text] [Related]

  • 15. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
    Johny AA, Clark A, Price N, Carrington D, Oakhill A, Marks DI.
    Bone Marrow Transplant; 2002 Jan 25; 29(2):113-5. PubMed ID: 11850704
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks.
    Schilling M, Povinelli L, Krause P, Gravenstein M, Ambrozaitis A, Jones HH, Drinka P, Shult P, Powers D, Gravenstein S.
    Vaccine; 1998 Nov 25; 16(18):1771-4. PubMed ID: 9778755
    [Abstract] [Full Text] [Related]

  • 17. Zanamivir. No noticeable progress against influenza.
    Can Fam Physician; 2000 Oct 25; 46():2003-8, 2012-8. PubMed ID: 11184246
    [Abstract] [Full Text] [Related]

  • 18. Patient perspective on zanamivir in the treatment of influenza.
    Bricaire F, Cohen JM, Jacquet M, Boucot I, Nicolas M, JAG Committee. Journée d'Actualites Grippe.
    Int J Clin Pract; 2002 Oct 25; 56(1):7-10. PubMed ID: 11831842
    [Abstract] [Full Text] [Related]

  • 19. Zanamivir: an update of its use in influenza.
    Cheer SM, Wagstaff AJ.
    Drugs; 2002 Oct 25; 62(1):71-106. PubMed ID: 11790157
    [Abstract] [Full Text] [Related]

  • 20. [Influenza: from vaccine prevention to antiviral therapy].
    Nkoghe D, Scheen AJ.
    Rev Med Liege; 2000 Jan 25; 55(1):19-23. PubMed ID: 10803033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.